Home Pharma China Web Edition Pharma China Archives Online Databases Subscription/Order/Info Event Calendar China Pharma Providers About Us
Location: Home > Pharma China Web Edition > Industry News    
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Featured News
Expert Opinions
Case Studies
Company Profiles
Editor´s Picks
WiCON International Group
311 Sayre Drive,
Princeton, NJ 08540, USA
Tel/Fax: +1 702-9953905

China Head Office
c/o Beijing Jicai PharmTech
Suite B-17D, Oriental Kenzo Plaza
48 Dongzhimenwai Dajie
Dongcheng District
Beijing 100027, China
Tel: +86 10 84476010
Fax: +86 10 84476010
Industry News
China's Economic Retaliation against South Korea Spreads to Healt... 3/29/2017
India Clears Fosun's Acquisition of Gland Pharma 3/29/2017
Korean Firm Alteogen to License Biosimilar Anticancer to Qilu Pha... 3/29/2017
XiAn Janssen under Major Reorganization 3/28/2017
Tsinghua University, Gates Foundation to Set Up Global Drug Disco... 3/28/2017
PwC: Chinese Pharma M&A to Remain Robust 3/27/2017
TaiGen Sells 9% Stake in HEC JV for $20M (free) 3/27/2017
Sihuan to Acquire Ambest Pharma for CNY 1.1 Bln 3/27/2017
CFDA Approves AZ's NSCLC Drug Tagrisso under Priority Review Path... 3/27/2017
2016 R&D Spending of 30 Listed Chinese Pharma Companies 3/24/2017
ShangPharma Announces Strategic Corporate Restructuring of Shangh... (free) 3/24/2017
David Ricks: China Is Now One of Eli Lilly's Core Markets 3/23/2017
Top In-licensing and Overseas M&A Deals in 2016 3/19/2017
18 Chinese Pharma Companies Launched IPO in February 3/19/2017
Snapshot of MNC Winners of New 2017 NRDL Listing 3/19/2017
Suzhou Ribo Secures CNY 270M in Series B Financing Round (free) 3/17/2017
Novartis to Reduce Prices of Two Originator Drugs in China 3/17/2017
Pfizer Announces CFDA Approval of RA Drug Xeljanz in China 3/17/2017
Snapshot of Chinese Pharma M&A Deals in 2016 3/16/2017
BGI Genomics Reinitiates IPO Application for Listing at Shenzhen'... 3/16/2017
Ally Bridge Backs Privatization Deal of Shandong Luoxin Private (free) 3/15/2017
Credit Suisse: BMI and Drug Price Reform to Reduce Pharma Growth ... 3/15/2017
Nhwa Licenses Long Acting Anti-psychotic Drug from Zysis 3/14/2017
CFDA Approves China's First SGLT2 Inhibitor for Type 2 Diabetes 3/13/2017
Novartis's Votrient Approved in China 3/12/2017
Pharmaron Acquires Majority Stake in CRO Shin Nippon Biomedical L... 3/10/2017
BeyondSpring Launches $54.3M Nasdaq IPO 3/10/2017
Fosun and Shanghai Pharma Reported to Join Bidding for Germany's ... 3/9/2017
CPhI China to Launch China Pharma Week (free) 3/9/2017
XW Labs Announces Licensing Deal with University of Pittsburgh to... 3/8/2017
Page:5/13    Total number of articles:364  :[1][2][3][4][5][>>][End]

© Wicon International Group  Support by: www.heightow.com   Site map | Contact Us | Links